Does TOFACITINIB Cause Therapy interrupted? 1,182 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 1,182 reports of Therapy interrupted have been filed in association with TOFACITINIB (XELJANZ XR). This represents 0.8% of all adverse event reports for TOFACITINIB.
1,182
Reports of Therapy interrupted with TOFACITINIB
0.8%
of all TOFACITINIB reports
0
Deaths
191
Hospitalizations
How Dangerous Is Therapy interrupted From TOFACITINIB?
Of the 1,182 reports, 191 (16.2%) required hospitalization, and 2 (0.2%) were considered life-threatening.
Is Therapy interrupted Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TOFACITINIB. However, 1,182 reports have been filed with the FAERS database.
What Other Side Effects Does TOFACITINIB Cause?
Drug ineffective (30,382)
Pain (21,659)
Condition aggravated (16,925)
Arthralgia (15,640)
Fatigue (13,551)
Rheumatoid arthritis (12,277)
Off label use (11,736)
Headache (11,061)
Joint swelling (10,686)
Malaise (9,040)
What Other Drugs Cause Therapy interrupted?
ADALIMUMAB (5,755)
ETANERCEPT (3,397)
RELUGOLIX (3,251)
CERTOLIZUMAB PEGOL (3,209)
LENALIDOMIDE (2,724)
UPADACITINIB (1,741)
ABATACEPT (1,726)
CLOZAPINE (1,722)
AMIKACIN (1,283)
SECUKINUMAB (1,071)
Which TOFACITINIB Alternatives Have Lower Therapy interrupted Risk?
TOFACITINIB vs TOFERSEN
TOFACITINIB vs TOLNAFTATE
TOFACITINIB vs TOLODODEKIN ALFA
TOFACITINIB vs TOLTERODINE
TOFACITINIB vs TOLVAPTAN